About
Thomas Goebel joined NeoMed Management in 2005 as a Senior Associate and became a Principal in 2008. He has over 10 years of experience of venture capital investing in healthcare in Europe. Previously Thomas was a global biotechnology analyst for Pictet & Cie, Switzerland's largest private bank. He was also Manager of Regulatory Affairs with worldwide responsibilities at Firmenich SA, a global leader in fragrances, flavourings and fine chemicals. Thomas has been a board member of Sequana Medical AG, and a board observer of Novexel SA and currently serves on the board of directors of Diagnoplex SA and Kuros Biosurgery AG. Thomas holds a Ph.D. in molecular biology form the University of Geneva, Switzerland.
Position in the VCSift Database
- • 3 investors at Neomed Management are tracked.
- • 658 investors hold the Principal role in VCSift. Thomas Goebel is one of them.
- • 284 investors are based in Geneva, Geneve, Switzerland.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Geneva, Switzerland
Contact Information
Find more investors like Thomas
Search Investors